Potassium Chloride Tablet, Film Coated, Extended Release
Product Images NDC 0378-4561

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 0378-4561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Potassium Chloride Extended-Release Tablets, USP 8 mEq (600 mg), film-coated, oral tablets in a 90-count package. Manufactured by Mylan Pharmaceuticals Inc., the label indicates instructions for storage, patient information, and tamper-evident packaging. The label also displays the NDC 0378-4560-77 and includes dosage guidance and safety warnings.*

FDA Label Image

Image 02

Packaging label of Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg) strength, film-coated, extended release oral tablets by Mylan Pharmaceuticals Inc. The label includes dosage warnings, storage instructions, and product identification with NDC 0378-4561-77. The package contains 90 tablets. The product is manufactured in India and distributed by Mylan Pharmaceuticals Inc., Morgantown, WV.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.